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Abstract
Molecular diagnosis of monogenic diabetes and obesity is of paramount importance for
both the patient and society, as it can result in personalized medicine associated with a bet-
ter life and it eventually saves health care spending. Genetic clinical laboratories are cur-
rently switching from Sanger sequencing to next-generation sequencing (NGS) approaches
but choosing the optimal protocols is not easy. Here, we compared the sequencing cover-
age of 43 genes involved in monogenic forms of diabetes and obesity, and variant detection
rates, resulting from four enrichment methods based on the sonication of DNA (Agilent Sur-
eSelect, RainDance technologies), or using enzymes for DNA fragmentation (Illumina Nex-
tera, Agilent HaloPlex). We analyzed coding exons and untranslated regions of the 43
genes involved in monogenic diabetes and obesity. We found that none of the methods
achieves yet full sequencing of the gene targets. Nonetheless, the RainDance, SureSelect
and HaloPlex enrichment methods led to the best sequencing coverage of the targets; while
the Nextera method resulted in the poorest sequencing coverage. Although the sequencing
coverage was high, we unexpectedly found that the HaloPlex method missed 20% of vari-
ants detected by the three other methods and Nextera missed 10%. The question of which
NGS technique for genetic diagnosis yields the highest diagnosis rate is frequently dis-
cussed in the literature and the response is still unclear. Here, we showed that the Rain-
Dance enrichment method as well as SureSelect, which are both based on the sonication of
DNA, resulted in a good sequencing quality and variant detection, while the use of enzymes
to fragment DNA (HaloPlex or Nextera) might not be the best strategy to get an accurate
sequencing.
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Introduction
Diagnostic testing for monogenic forms of diabetes and obesity is of paramount importance
for the patient and his/her family as it can lead to personalized medicine associated with a bet-
ter life. Indeed, the patients presenting with neonatal diabetes mellitus (NDM), maturity-onset
diabetes of the young (MODY), or adult onset atypical type 2 diabetes, who carry a heterozy-
gous mutation in ABCC8 or KNCJ11 (encoding subunits of the ATP-dependent potassium
channel at the membrane of pancreatic beta cells), can be successfully switched from an expan-
sive and demanding insulin therapy to easy and cheap oral sulfonylureas, with much better
result on glucose control [1]. Furthermore, MODY patients with a heterozygous mutation in
HNF1A (MODY-3) can also be optimally treated with an oral sulfonylurea agent [2]. For soci-
ety, it has been demonstrated that diagnosis of MODY and NDM save life and money, as
degenerative complications can be avoided at lower costs [3,4].
Among the patients with severe, early-onset obesity, the carriers of a homozygous mutation
in the leptin gene (LEP) can be treated with recombinant leptin therapy, which leads to a
marked and sustained reduction in weight [5]. In countries with high levels of consanguinity,
one of five severely obese patients carries a mutation in LEP [6]. The development of quick,
reliable and cost-effective protocols for genetic diagnosis of diabetes and obesity are limiting
factors for precision medicine in metabolic diseases.
Most of genetic diagnostic laboratories are currently moving from Sanger sequencing to
next-generation sequencing (NGS) approaches but it is not clear which enrichment method
yields better specificity and sensitivity in the field of monogenic diabetes and obesity, resulting
in the most accurate variant detection.
In the present study, we aim to compare four different enrichment solutions based on the
sonication of DNA (SureSelect Human All Exon, Raindance microdroplet-based PCR enrich-
ment), or using enzymes for the fragmentation of DNA (Nextera Rapid Capture Expanded
Exome, HaloPlex Custom Kit), in combination with Illumina NGS. To assess these four meth-
ods, we processed DNA samples from two MODY patients with a known causal mutation in
HNF1B, and then we compare sequencing coverage of targeted regions and variant detection.
To our knowledge, this is the first time a head-to-head technical comparison is made between
these four techniques.
Methods
Patient Selection
We selected two patients presenting with MODY, who were previously diagnosed for a causal
mutation inHNF1B (NM_000458.2). The study protocol was approved by local ethic commit-
tees (Cruces University Hospital—Centro de Investigaciὀn Biomédica en Red de Diabetes y
Enfermedades Metabὀlicas Asociada, Barakaldo, Spain), and study participants signed an
informed consent.
RainDance Microdroplet-Based PCR Enrichment
A custom panel was designed to target exons and untranslated regions (UTRs; including
5’UTRs and 3’UTRs) with 50 base-pairs (bp) of intronic flanking regions, of a total of 43 genes
involved in monogenic forms of diabetes (ABCC8, CEL, EIF2AK3, FOXP3, GCK, GLIS3,
HNF1A, HNF1B, HNF4A, INS, KCNJ11, NEUROD1, NEUROG3, PDX1, PTF1A, RFX6 and
WFS1) and obesity (ALMS1, ARL6, BBS1, BBS2, BBS4, BBS5, BBS7, BBS9, BBS10, BBS12,
BDNF, CEP290, GNAS, LEP, LEPR,MC4R,MKKS,MKS1, NTRK2, PCSK1, POMC, SDCCAG8,
SIM1, TRIM32, TTC8,WDPCP), as previously described [7]. Of note, all transcripts were
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included in the panel. The two DNA samples were processed following the manufacturer’s pro-
tocols. Briefly, genomic DNA was sonicated (Bioruptor NGS; Diagenode, Liège, Belgium) and
added to a PCR mix. Subsequently, the RainDance primer library was merged with each sample
mix on the RDT1000 (RainDance Technologies, Billerica, MA, USA). The resulting emulsion
was amplified by PCR and used for library construction. Finally, the two samples were
sequenced through Illumina technology (MiSeq; Illumina, San Diego, CA, USA).
Agilent SureSelect Whole-Exome Target Enrichment
The two DNA samples were also processed using Agilent SureSelectXT Human All Exon Kit
(version V5+UTRs; Agilent Technologies, CA, USA), following the manufacturer’s protocol as
previously described [8]. The two whole-exome DNA librairies were sequenced through Illu-
mina technology (HiSeq2500).
Agilent HaloPlex Target Enrichment
The two DNA samples were also processed using a custom Haloplex panel (Agilent Technolo-
gies), which was designed using Agilent’s online design tool to target the same regions that
were targeted by the RainDance assay (please see above). The total amplicon number was 9,991
and the target size was 230.7 kb with a theoretical coverage of 99.2% for our targeted regions.
Target enrichment was performed according to the manufacturer's protocol for Illumina
Sequencing (Version D.5; Agilent Technologies). The two DNA samples were split into 8 dif-
ferent reactions, each containing two restriction enzymes. Subsequently, all reactions were
pooled back into one single tube, resulting in a digested DNA sample containing both targeted
and non-targeted regions of the genome. The DNA sample was mixed with probes and hybrid-
ized overnight. Each end of the probe was complementary to a part of the single-stranded
DNA fragments, and the center part was double stranded and comprised a cassette with the
Illumina sequence motifs. Thousands of probes targeting different regions were added in this
step, guiding circularization of the targeted fragments. The probes contained biotin, enabling
the capture on streptavidin coated paramagnetic beads. Using a magnet rack, the targeted frag-
ments were captured along with probes whereas other parts of the genome were discarded by
removing the supernatant. Fragments correctly hybridized to their corresponding probe
formed templates for a DNA ligase. Ligation resulted in the formation of closed DNA circles of
targeted fragments. The targeted fragments were subsequently amplified by PCR. Sequence
motifs needed for Illumina sequencing were associated, including sample barcodes which
allowed samples to be pooled after this step. The samples were sequenced through Illumina
technology (MiSeq).
Nextera Rapid Capture Expanded Exome
The two DNA samples were lastly processed using Nextera Rapid Capture Expanded Exome
(Illumina), applying pre-capture multiplexing, according to the manufacturer's protocol. A tag-
mentation was performed with the Nextera transposome (Illumina), which fragments the
genomic DNA and adds adapter sequences allowing amplification by PCR. The process of
enrichment involved two hybridizations so as to increase the specificity of the captured regions.
A second PCR amplification step increased the amount of enriched DNA library for sequenc-
ing. The two samples were sequenced through Illumina technology (HiSeq2500).
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Sanger sequencing
The 10 mutations that were detected by only one or two enrichment technologies were investi-
gated by a standard Sanger sequencing. Primer sequences and PCR conditions are available
upon request. Amplified fragments were bidirectionally sequenced and analyzed using the
automated 3730xl DNA Analyzer (Applied Biosystems, Waltham, MA, USA). Electrophore-
gram reads were assembled and read using Variant Reporter software (Applied Biosystems).
Data Analysis
Demultiplexing of sequence data were performed with CASAVA (version 1.8.2). Subsequently,
sequence reads from FASTQ files were mapped to the human genome (hg19/GRC37) using
the Burrows-Wheeler Aligner (version 0.6.1; algorithm "BWA-SW"; default parameters) for
targeted sequencing data, and CASAVA software (version 1.8.2, Illumina) for whole exome
sequencing (WES) data. Variant calling was performed with SAMtools (version 0.1.18; algo-
rithm "pileup" with the following parameters:-u -g -B -m 3 -C 50 -d 1000000 -L 1000000 -F
0.0002 -Q 0) for targeted sequencing data, and CASAVA software for WES data. The output
VCF files were filtered using quality threshold of read depth 8×. All detected variants were
annotated using the Ensembl Perl API (version 71) and other Perl scripts to include data from
dbSNP and dbNSFP. The coverage for each targeted region as well as other quality control sta-
tistics was obtained by in-house Perl scripts and Bedtools 2.17. Through the four enrichment
technologies (RainDance, Agilent SureSelect, Agilent HaloPlex and Nextera) in combination
with Illumina sequencing, we always obtained a mean read depth higher than 100× for both
samples.
Importantly, so as to avoid any biases, we only analyzed the intersection of the four BED
files (related to RainDance, Agilent SureSelect, Agilent HaloPlex and Nextera), which included
coding exons and UTRs with 10 bp of intronic flanking regions, of the 43 genes involved in
monogenic forms of diabetes and obesity. Therefore, the analysis was restricted to the regions
covered in theory by all the enrichment methods.
Results
We first compared the mean percentage of base-pairs covered by 8, 20, 50 or 100 sequence
reads in coding regions (with 10 bp of intronic flanking regions) of the 43 targeted genes,
according to each enrichment method (Fig 1). The mean percentage of base-pairs covered by
8 reads was quite similar between the four methods (from 97.9% for Nextera to 99.3% for Sure-
Select; Fig 1). However, when we consider a read depth ranging from 20 to 100×, only the
RainDance enrichment method led to a good quality of sequencing coverage, with a mean per-
centage of covered base-pairs higher than 95% (Fig 1). The SureSelect and Haloplex methods
led to a similar sequencing quality with a mean percentage of covered base-pairs of ~85%, at
read depth of 100× (Fig 1). The Nextera method led to a poor sequencing quality right from a
read depth of 20× (Fig 1).
Subsequently, using the same method, we analyzed the sequencing quality of UTRs sepa-
rately as mutations in UTRs do not lead to highly straightforward interpretation, although they
may be important for studying possible disruption of binding sites of both transcription factors
in 5’UTRs and miRNAs in 3’UTRs. Sequencing qualities resulting from the RainDance and
SureSelect enrichment methods were both quite good, with a mean percentage of covered base-
pairs higher than 90%, at read depth of 100× (Fig 2). Sequencing qualities resulting from the
HaloPlex and Nextera enrichment methods were poorer, with a mean percentage of covered
base-pairs of 79.7% and 41.6% respectively, at read depth of 100× (Fig 2).
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Subsequently, we compared the number of regions (coding exons or UTRs) fully covered
according to each enrichment method, at read depth of 8×, 20×, 50× or 100× (Figs 3 and 4); so
as to know if the missing base-pairs were uniformly distributed in the target or were present at
specific loci (which would facilitate an eventual resequencing). The profile of covered coding
regions (Fig 3) and covered UTRs (Fig 4) at the different read depths (8×, 20×, 50× or 100×)
was in fact very similar to what was observed in Figs 1 and 2 respectively (with a correlation
[r²] higher than 0.9). Taken as a whole, the number of fully covered regions was higher for
RainDance, slightly lower for SureSelect and HaloPlex, and much lower for Nextera (Figs 3
and 4). For a clinical diagnosis purpose, few regions had to be resequenced when having used
RainDance, SureSelect or HaloPlex enrichment methods; but a lot more regions needed to be
reassessed when having used the Nextera method.
Subsequently, we compared the number of detected variants in the targeted genes (coding
exons and UTRs, with 10 bp of intronic flanking regions) according to each enrichment
method. When variants were detected by two different methods or less, we performed Sanger
sequencing to validate or not the presence of these variants (S1 Fig). When variants were
detected by at least three different methods, we considered that these variants were real. Unex-
pectedly, we found that the HaloPlex enrichment method led to high false negative rate (24%
for Patient #1 and 20% for Patient #2; Fig 5), despite a good sequencing coverage (Figs 1, 2, 3
and 4). To a lesser extent, the Nextera enrichment method also missed some variants (7% for
Patient #1 and 11% for Patient #2; Fig 5). Of note, the vast majority (> 90%) of the missing
variants resulting from both HaloPlex and Nextera enrichment methods had an ID in dbSNP
database (S1 Table). Moreover, these two enrichment methods led to false positive variants
(from one to three variants in both patients; Fig 5). Of note, all these variants did not have any
Fig 1. Percentage of base-pairs covered by 8, 20, 50 or 100 sequence reads in coding regions of targeted genes (with 10 bp of intronic flanking
regions), according to each enrichment method.
doi:10.1371/journal.pone.0143373.g001
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ID in dbSNP database (S1 Table) and the read depths at these loci were between 10 and 50×
(S1 Fig). Nonetheless, it is noteworthy that all enrichment methods (including Nextera and
Haloplex) did identify the mutation causing MODY in each patient (p.Gln382 in HNF1B for
Patient #1 and p.His69_Lys71delinsArg inHNF1B for Patient #2; S1 Table).
Discussion
In the present study, we compared four different enrichment methods including SureSelect,
Nextera, HaloPlex and RainDance, in two patients presenting with MODY. The analyses were
focused on genes (coding regions and UTRs) involved in monogenic forms of diabetes and
obesity. We found that none of the methods led to full sequencing of the targets. Nonetheless,
the RainDance, SureSelect and HaloPlex methods led to the best sequencing coverage of coding
regions and UTRs; while the Nextera method led to a poor sequencing coverage. To get an
exhaustive sequencing coverage of the target, there are several options:
1. to resequence the missing targets through Sanger sequencing, although it could be obviously
labor-intensive and time-consuming;
2. to improve the low coverage in the missing targets through the combination of two NGS
enrichment methods. For instance, Miya et al. have recently combined the SureSelect and
HaloPlex methods in such a way that HaloPlex was used to target the protein-coding
sequences with a read depth<15× in the SureSelect results [9].
3. to improve the low coverage in the missing targets by changing the design of amplicons tar-
geting these low-covered regions (in the HaloPlex or RainDance libraries for instance)
Fig 2. Percentage of base-pairs covered by 8, 20, 50 or 100 sequence reads in UTRs of targeted genes, according to each enrichment method.
doi:10.1371/journal.pone.0143373.g002
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[7,10]. Indeed, the use of primers could lead to specificity issues through their hybridization
at multiple loci of the genome or in cases where they target a locus containing a genetic
variant.
4. to improve the low coverage in the missing targets by adding more probes (baits) targeting
these low-covered regions (in the SureSelect libraries for instance). One company, Persona-
lis, and two universities, Baylor College of Medicine and Emory Genetics Laboratory, are
currently providing a ‘medical exome’ with an enhanced coverage for disease-associated
genes, which improves the yield of molecular diagnosis of genetic diseases [11].
When we compared the detection of variants according to enrichment methods, we unex-
pectedly found that the HaloPlex method missed about 20% of variants, while the sequencing
coverage was high. We also found some false negative variants through the use of Nextera.
These missing variants may be explained by the use of enzymes by both HaloPlex and Nextera
methods. Nextera strategy indeed relies on the tagmentation which is the use of a transposase
to fragment DNA and to add adapters for multiplexing and sequencing. This transposase cre-
ates DNA fragments with a broad size range distribution, typically between 300-1000bp. The
first issue is that all the DNA fragments are larger than the sequencing reads. Therefore, even
with an enrichment step, some of the DNA fragments will be sequenced targeting regions of
interest but also an unintended part that could be important depending on the size of the frag-
ment. This phenomenon creates off-target in the sequencing data which results in a lower cov-
erage for the same amount of library as a SureSelect library for instance. The second issue
involves the concentration of input genomic DNA which has to be very accurate and propor-
tional to the quantity of transposomes, otherwise the size distribution of the library will not be
Fig 3. Number of coding exons (with 10 bp of intronic flanking regions; ntotal = 576) exhaustively covered by 8, 20, 50 or 100 sequence reads,
according to each enrichment method.
doi:10.1371/journal.pone.0143373.g003
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in the expected range. The third issue of transposome is a bias towards target regions with high
GC content [12]. All these reasons could explain false positive/negative rates but it may also be
due to other critical steps of library preparation like the number of PCR cycles and purification
steps. However, we have to acknowledge that one of the limitations of our study is the use of
different Illumina sequencers (MiSeq and HiSeq), even if we used the same chemistry (flowcell,
cluster generation process, paired-end reads). Moreover, we analyzed two DNA samples only,
which is another limitation. Further studies are needed to confirm the present results.
The question of which NGS technique yields the highest diagnosis rate is frequently dis-
cussed in the literature and is still open. It has been demonstrated that whole-genome sequenc-
ing (WGS) was more appropriate as copy number variants (CNVs) can be detected more
accurately [13]. Some other groups have shown that whole-exome sequencing (WES) was a
good alternative to WGS as it costs three to four times less and the results in term of variants
are very similar [14]. Finally, some panel-based genetic testing studies, including our present
study, have been demonstrated to lead to better results than WES with a higher sensitivity and
specificity [15]. Actually, the answer relative to the best NGS method for genetic testing may
depend on the studied disease itself: a disease which is known to involve CNVs or big structural
changes like severe intellectual disability and autism will require WGS. However, WES is still
cost-effective for many diseases and may require technical modifications to get a good coverage
for the genes specific to the disease of interest. Finally, target sequencing is still in many cases
the best method as it is very accurate, cost-effective, and is much quicker and easier to interpret
as the number of genes is limited and there are not any incidental findings to report. Impor-
tantly, we have shown here that the use of enzymes to fragment DNA (either in target sequenc-
ing [HaloPlex] or WES [Nextera]) might be not the best strategy to get an accurate sequencing.
Fig 4. Number of UTRs (ntotal = 197) exhaustively covered by 8, 20, 50 or 100 sequence reads, according to each enrichment method.
doi:10.1371/journal.pone.0143373.g004
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